TY - JOUR
T1 - Risk Score for Prediction of Dialysis After Transcatheter Aortic Valve Replacement
AU - Pasceri, Vincenzo
AU - Pelliccia, Francesco
AU - Mehran, Roxana
AU - Dangas, George
AU - Porto, Italo
AU - Radico, Francesco
AU - Biancari, Fausto
AU - D’ascenzo, Fabrizio
AU - Saia, Francesco
AU - Luzi, Giampaolo
AU - Bedogni, Francesco
AU - Amat Santos, Ignacio J.
AU - De Marzo, Vincenzo
AU - Dimagli, Arnaldo
AU - Mäkikallio, Timo
AU - Stabile, Eugenio
AU - Blasco-Turrión, Sara
AU - Testa, Luca
AU - Barbanti, Marco
AU - Tamburino, Corrado
AU - Fabiocchi, Franco
AU - Chilmeran, Ahmed
AU - Conrotto, Federico
AU - Costa, Giuliano
AU - Stefanini, Giulio
AU - Spaccarotella, Carmen
AU - Macchione, Andrea
AU - La Torre, Michele
AU - Bendandi, Francesco
AU - Juvonen, Tatu
AU - Wańha, Wojciech
AU - Wojakowski, Wojtek
AU - Benedetto, Umberto
AU - Indolfi, Ciro
AU - Hildick-Smith, David
AU - Zimarino, Marco
N1 - Publisher Copyright:
© 2024 The Authors.
PY - 2024/4/2
Y1 - 2024/4/2
N2 - BACKGROUND: Dialysis is a rare but serious complication after transcatheter aortic valve replacement. We analyzed the large multicenter TRITAVI (transfusion requirements in transcatheter aortic valve implantation) registry in order to develop and validate a clinical score assessing this risk. METHODS AND RESULTS: A total of 10 071 consecutive patients were enrolled in 19 European centers. Patients were randomly assigned (2:1) to a derivation and validation cohort. Two scores were developed, 1 including only preprocedural variables (TRITAVIpre) and 1 also including procedural variables (TRITAVIpost). In the 6714 patients of the derivation cohort (age 82±6 years, 48% men), preprocedural factors independently associated with dialysis and included in the TRITAVIpre score were male sex, diabetes, prior coronary artery bypass graft, anemia, nonfemoral access, and creatinine clearance <30 mL/ min per m2. Additional independent predictors among procedural features were volume of contrast, need for transfusion, and major vascular complications. Both scores showed a good discrimination power for identifying risk for dialysis with C-statistic 0.78 for TRITAVIpre and C-statistic 0.88 for TRITAVIpost score. Need for dialysis increased from the lowest to the highest of 3 risk score groups (from 0.3% to 3.9% for TRITAVIpre score and from 0.1% to 6.2% for TRITAVIpost score). Analysis of the 3357 patients of the validation cohort (age 82±7 years, 48% men) confirmed the good discrimination power of both scores (C-statistic 0.80 for TRITAVIpre and 0.81 for TRITAVIpost score). Need for dialysis was associated with a significant increase in 1-year mortality (from 6.9% to 54.4%; P=0.0001). CONCLUSIONS: A simple preprocedural clinical score can help predict the risk of dialysis after transcatheter aortic valve replacement.
AB - BACKGROUND: Dialysis is a rare but serious complication after transcatheter aortic valve replacement. We analyzed the large multicenter TRITAVI (transfusion requirements in transcatheter aortic valve implantation) registry in order to develop and validate a clinical score assessing this risk. METHODS AND RESULTS: A total of 10 071 consecutive patients were enrolled in 19 European centers. Patients were randomly assigned (2:1) to a derivation and validation cohort. Two scores were developed, 1 including only preprocedural variables (TRITAVIpre) and 1 also including procedural variables (TRITAVIpost). In the 6714 patients of the derivation cohort (age 82±6 years, 48% men), preprocedural factors independently associated with dialysis and included in the TRITAVIpre score were male sex, diabetes, prior coronary artery bypass graft, anemia, nonfemoral access, and creatinine clearance <30 mL/ min per m2. Additional independent predictors among procedural features were volume of contrast, need for transfusion, and major vascular complications. Both scores showed a good discrimination power for identifying risk for dialysis with C-statistic 0.78 for TRITAVIpre and C-statistic 0.88 for TRITAVIpost score. Need for dialysis increased from the lowest to the highest of 3 risk score groups (from 0.3% to 3.9% for TRITAVIpre score and from 0.1% to 6.2% for TRITAVIpost score). Analysis of the 3357 patients of the validation cohort (age 82±7 years, 48% men) confirmed the good discrimination power of both scores (C-statistic 0.80 for TRITAVIpre and 0.81 for TRITAVIpost score). Need for dialysis was associated with a significant increase in 1-year mortality (from 6.9% to 54.4%; P=0.0001). CONCLUSIONS: A simple preprocedural clinical score can help predict the risk of dialysis after transcatheter aortic valve replacement.
KW - acute kidney injury
KW - dialysis
KW - mortality
KW - risk score
KW - transcatheter aortic valve replacement
KW - 3121 General medicine, internal medicine and other clinical medicine
U2 - 10.1161/JAHA.123.032955
DO - 10.1161/JAHA.123.032955
M3 - Article
C2 - 38533944
AN - SCOPUS:85189760743
SN - 2047-9980
VL - 13
JO - Journal of the American Heart Association
JF - Journal of the American Heart Association
IS - 7
M1 - e032955
ER -